screening mammography and the benefits of adjuvant systemic therapies, the mortality rate due to breast cancer has decreased over the past 25 years. 2 Nonetheless, considerable professional disagreement exists over the most appropriate age at which to begin
Search Results
Differences in Patient Screening Mammography Rates Associated With Internist Gender and Level of Training and Change Following the 2009 U.S. Preventive Services Task Force Guidelines
Dawn J. Brooks
Using the Science of Psychosocial Care to Implement the New American College of Surgeons Commission on Cancer Distress Screening Standard
Lynne I. Wagner, David Spiegel, and Timothy Pearman
, palliative care services, genetics services, navigation programs, and psychosocial distress screening. 1 The inclusion of distress screening builds on accomplishments of the NCCN Distress Management Panel 2 to advance screening as a component of quality
Insights Into Preferences for Psycho-Oncology Services Among Women With Gynecologic Cancer Following Distress Screening
Sylvie D. Lambert, Brian Kelly, Allison Boyes, Alexander Cameron, Catherine Adams, Anthony Proietto, and Afaf Girgis
distress screening programs in cancer care as a way of improving the management of distress. Routine distress screening at periods of increased vulnerability is now an integral part of international cancer control plans 7 , 8 and best practice guidelines
HSR19-079: Disparities in Accessing Screening Mammography: Opportunities for Improving Diagnostic Outcomes
Nila Alsheik, Zhaohui Su, Anna Lafontant, Gregory Donadio, Kathleen Troeger, Scott Pohlman, Melinda Talley, Vandana Menon, and Emily Conant
Introduction: Screening mammography is a key component of secondary prevention programs targeting reductions in breast cancer mortality. The early detection of cancers facilitates treatment at a more curable, locoregionally limited stage. We
Secondary Neoplasms of the Female Lower Genital Tract After Hematopoietic Cell Transplantation
Howard A. Chang, Saro H. Armenian, and Thanh H. Dellinger
with HPV will mount an effective immune response to clear the infection within 2 years. 18 Those who are unable to do so may develop cervical, vulvar, or vaginal dysplasia. Screening with Papanicolaou (Pap) smears detects cytologic abnormalities such
Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer
Philip J. Saylor and Matthew R. Smith
treated with ADT, a statistically significant ADT-associated elevation in the risk for diabetes was observed (HR, 1.16; 95% CI, 1.11–1.21). The observed greater risk for diabetes in these analyses argues for diabetes screening among men on ADT. Diabetes
Cancer-Related Fatigue
Ann M. Berger, Amy Pickar Abernethy, Ashley Atkinson, Andrea M. Barsevick, William S. Breitbart, David Cella, Bernadine Cimprich, Charles Cleeland, Mario A. Eisenberger, Carmen P. Escalante, Paul B. Jacobsen, Phyllis Kaldor, Jennifer A. Ligibel, Barbara A. Murphy, Tracey O'Connor, William F. Pirl, Eve Rodler, Hope S. Rugo, Jay Thomas, and Lynne I. Wagner
clinically indicated. Screening should identify fatigue. Patients and families should be informed that managing fatigue is an integral part of total health care, and all patients should undergo symptom management. Furthermore, if patients cannot tolerate
A Survey of the National Comprehensive Cancer Network on Approaches Toward Addressing Patients’ Transportation Insecurity
Krisda H. Chaiyachati, Diana Krause, Jessica Sugalski, Evan M. Graboyes, and Lawrence N. Shulman
Institutional Review Board. Results In total, 25 of 31 (81%) NCCN Member Institutions responded to the survey. Among the respondents, 24 (96%) supported the transportation needs of patients by implementing processes for screening, coordinating, or
The Potential Utility of HPV Genotyping in Screening and Clinical Management
Philip E. Castle
: Cervix Cancer Screening . Lyon, France : IARC Press ; 2005 . 2. Jemal A Siegel R Ward E . Cancer statistics, 2007 . CA Cancer J Clin 2007 ; 57 : 43 – 66 . 3. Kitchener HC Castle PE Cox JT . Chapter 7: achievements and
BPI19-012: Differences in Stakeholder Perspectives Regarding Key Components of Shared Decision-Making for Mammography in Breast Cancer Screening for Women Ages 40–50
Lori L. DuBenske, Sarina B. Schrager, Terry A. Little, and Elizabeth S. Burnside
Background: National health organizations offer contrasting guidelines for women aged 40–49 regarding when to begin and how often to use mammography screening for breast cancer. The ACS recommends average risk women aged 40–44 receive annual
